Ads by Google

Prescription Drugs

Business To Streamline, Personalize Support By Pharmaceutical Companies For Medical Professionals

PharmaMeal's new service allows medical professionals to create an online profile which includes important delivery information as well as staff meal preferences.

Health and Wellness: 

Orphan Australia Receives Approval For New Dose Form DepoDur

Orphan Australia Pty Ltd, dedicated to providing novel, highly specialized pharmaceuticals, has been granted registration approval by the Therapeutic Goods Administration for DepoDur in Australia. DepoDur, which was developed by and licensed from Pacira Pharmaceutical, Inc. and utilizes Pacira's DepoFoam technology, is a novel, single dose modified-release formulation of morphine.

Health and Wellness: 

Sequella Lead Drug Compound Receives Orphan Drug Status From FDA

FDA and the European Medicines Agency (EMEA) independently reviewed Sequella lead drug compound, SQ109, and both agencies granted SQ109 orphan drug status for the treatment of tuberculosis. SQ109 shows excellent in vitro and in vivo activity against drug-susceptible and drug-resistant TB bacteria, including XDR-TB.

Further, SQ109 synergizes with other TB drugs in experimental animal models of TB, and could result in new TB drug combinations that have much greater activity than the current standard of care.

Health and Wellness: 

FDA Cleares Allient Sorbent Hemodialysis System For Chronic, Acute Hemodialysis

Renal Solutions has received 510(k) clearance from FDA for its newly enhanced Allient Sorbent Hemodialysis System in chronic and acute hemodialysis applications. The new Allient System features improvements in ease of manufacturing, service and user-friendliness. In preparation for the Allient System commercialization, Renal Solutions is also launching its SMARRT (Sorbent Management for Advanced Renal Replacement Therapy) platform and campaign, which will introduce the benefits of advanced sorbent therapy to the renal community.

Health and Wellness: 

Optimizing Your Internal Process For FDA Compliance

With safety issues making headlines, pharmaceutical and medical device manufacturers face a rugged regulatory landscape. Organizations are relying on their quality function to navigate regulatory difficulties that could affect production. Proper staffing of quality roles is just one way organizations optimize their quality function and a study by pharmaceutical benchmarking leader Best Practices, LLC found best-in-class companies have a ratio of quality personnel to total manufacturing employees between 1:4 and 1:7.

Health and Wellness: 

Mammalian HSP90 Better Target For AIDS, Sepsis, Cancer Drugs

Scientists have just solved the structure of the first mammalian GRP94 protein implicated in immune diseases such as sepsis, AIDS and certain cancers. His work is being published today in a cover article in a top scientific journal -- Molecular Cell.

Health and Wellness: 

FDA Approves Drug To Treat Complicated Urinary Tract, Intra-Abdominal Infections

FDA has approved doripenem injection, 500 mg intravenous infusion, for the treatment of complicated urinary tract and intra-abdominal infections. Doripenem injection, sold under the trade name Doribax, has been shown to be active against several strains of bacteria.

"This is a significant new drug in the treatment of hospitalized patients with serious bacterial infections," said Janet Woodcock, M.D., FDA's deputy commissioner for scientific and medical programs, chief medical officer and acting director, Center for Drug Evaluation and Research.

Health and Wellness: 

Legislation To Allow Small Pharmacies To Collaborate On Negotiations With Health Insurers

Independent pharmacists urged lawmakers to pass legislation that would exempt small pharmacies from antitrust laws and allow them to collaboratively negotiate reimbursements with health insurers and pharmacy benefit managers.

Health and Wellness: 

Baxter Adds Recombinant ProteinTto Specialty Therapeutics Portfolio

Baxter International has signed an agreement with Kaketsuken, the Chemo-Sero-Therapeutic Research Institute, for the worldwide rights to develop, manufacture and market the recombinant protein ADAMTS13.

Health and Wellness: 

Independent Pharmacists Raise Concerns About New Medicaid Generic Drug Reimbursement Rule

Independent pharmacists express concerns about a rule finalized in July by CMS that will reduce Medicaid reimbursements to pharmacies for generic medications.

Health and Wellness: 

Medi-Scripts Prescription Pad Product Adds Patient Offers

Medi-Promotions launched next generation prescription pad model -- Medi-Scripts PLUS. Building on the 27-year success of its Medi-Scripts prescription pad service model, Medi-Scripts PLUS will include patient offers on behalf of its advertisers whom leverage the list of more than 200,000 Medi-Scripts prescribers requesting and using its prescription pads free of charge in their practices on a daily basis.

Health and Wellness: 

Genencor Launches Commercial Enzyme Product For Cellulosic Ethanol

Genencor announced a new product, Accellerase 1000, the first ever commercially available biomass enzyme developed specifically for second generation biorefineries. Accellerase 1000 contains a potent complex of enzymes that reduces complex lignocellulosic biomass into fermentable sugars -- an indispensable step for the production of cellulosic ethanol.

Health and Wellness: 

Knopp Neurosciences Receives Orphan Designation For KNS-760704 For Treatment Of ALS

FDA Office of Orphan Products Development has granted orphan drug designation to Knopp Neurosciences's KNS-760704 for the treatment of amyotrophic lateral sclerosis (ALS).

Health and Wellness: 

Private Insurers Do Not Receive Discounts From Drug Makers

Nearly $15 billion could have been saved this year if private insurers that offer Medicare prescription drug plans had administrative costs similar to those of Medicare and if they obtained discounts on drugs.

Health and Wellness: